Prospective randomized phase 2 trial of pancreaticogastrostomy versus pancreaticojejunostomy after pancreaticoduodenectomy

Prospective randomized phase 2 trial of pancreaticogastrostomy versus pancreaticojejunostomy after pancreaticoduodenectomy - Prospective randomized phase 2 trial of pancreaticogastrostomy versus pancreaticojejunostomy after pancreaticoduodenectomy

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

JPRN

Registry ID

JPRN-UMIN000011454

Enrollment

Registered

2013-08-11

Start date

2013-04-01

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Patients who need pancreaticoduodenectomy

Interventions

Pancreaticogastrostomy Pancreaticojejunostomy

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: (1) Patients who need pancreaticooduodenectomy (2) ECOG performance status of 0 or 1 (3) Age of 20 and more (4) Patients without any distant metastases (5) Adequate hematologic, hepatic, renal and respiratory function (6) Written informed consent

Exclusion criteria

Exclusion criteria: (1) Severe liver cirrhosis or severe active hepatitis (2) Severe pulmonary disorders (3) Severe renal disorders (4) Active double cancer except carcinoma in situ or intramucosal cancer (synchronous double cancer or asynchronous double cancer with disease-free duration to be within 2 years) (5) Hypersensitivity to eggs (6) As determined by the principal investigator or the sub-investigator the subject is not adequate to participate in the trial.

Design outcomes

Primary

Measure	Time frame
The incidence of delayed gastric emptying evaluated by ISGPS criteria	—

Countries

Japan

Contacts

Public ContactHidetoshi Eguchi

Osaka University Gastroenterological Surgery

heguchi@gesurg.med.osaka-u.ac.jp06-6879-3251

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026